AUSTIN, Texas, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Aspira Women's Health Inc. ("Aspira" or the "Company") (NASDAQ:AWH), a bio-analytical based women's health company focused on the development of gynecologic disease diagnostic tools, today announced that management will present a corporate overview at The Cancer Advocacy Group of Louisiana's 3rd Annual NeauxCancer Conference taking place in New Orleans, Louisiana on February 29 to March 2, 2024. Management will be available for one-on-one meetings with investors who are registered for the conference.
Presentation Details: | |
Date: | Friday, March 1, 2024 |
Time: | 9:30 am CST / 10:30 am EST |
Webcast: | Click HERE to view the presentation |
Registration: | Click HERE to register and attend the conference |
About CAGLA
The Cancer Advocacy Group of Louisiana, Inc. (CAGLA) is a grassroots, non-profit advocacy organization committed to enhancing cancer care and research in Louisiana. The NeauxCancer Conference is an annual multi-day, multi-track CME/CE conference that attracts over 400 leaders in oncology, including medical oncologists, cancer surgeons, radiation oncologists, as well as advanced practice providers, medical trainees, nurses, pharmacists, and other ...